BLCM - Bellicum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 555.51M
Enterprise Value 342.2M
Trailing P/E N/A
Forward P/E 1-0.78
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)22.10
Price/Book (mrq)1.83
Enterprise Value/Revenue 316.81
Enterprise Value/EBITDA 6-0.46

Trading Information

Stock Price History

Beta (3Y Monthly) 1.64
52-Week Change 3-81.05%
S&P500 52-Week Change 33.55%
52 Week High 36.6400
52 Week Low 30.7800
50-Day Moving Average 31.1791
200-Day Moving Average 32.2796

Share Statistics

Avg Vol (3 month) 3801.93k
Avg Vol (10 day) 3652.43k
Shares Outstanding 546.25M
Float 37.91M
% Held by Insiders 15.24%
% Held by Institutions 153.79%
Shares Short (Aug 15, 2019) 41.51M
Short Ratio (Aug 15, 2019) 43.48
Short % of Float (Aug 15, 2019) 43.35%
Short % of Shares Outstanding (Aug 15, 2019) 43.25%
Shares Short (prior month Jul 15, 2019) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-3,975.39%

Management Effectiveness

Return on Assets (ttm)-49.49%
Return on Equity (ttm)-143.49%

Income Statement

Revenue (ttm)2.51M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)284.30%
Gross Profit (ttm)-70.47M
EBITDA -92.55M
Net Income Avi to Common (ttm)-102.48M
Diluted EPS (ttm)-2.3140
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.57M
Total Cash Per Share (mrq)1.22
Total Debt (mrq)43.72M
Total Debt/Equity (mrq)144.26
Current Ratio (mrq)2.67
Book Value Per Share (mrq)0.65

Cash Flow Statement

Operating Cash Flow (ttm)-83.13M
Levered Free Cash Flow (ttm)-43.49M